Local Betamethasone Versus Triamcinolone Injection in Management of Thyroid Eye Disease
Thyroid Eye Disease
About this trial
This is an interventional treatment trial for Thyroid Eye Disease
Eligibility Criteria
Inclusion Criteria:
- Clinical diagnosis of Thyroid Eye Disease.
- Thyroid function within normal range.
Exclusion Criteria:
- Patients on systemic steroid and or immunosuppressive therapy.
- Patients underwent thyroidectomy.
- Sight threatening (severe) TED which requires immediate surgery.
- Patients with fibrotic ocular muscles who need surgery.
- Contraindications to steroid therapy as in pregnant women.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
Experimental
A1 peri-levator betamethasone injection
A2 Peri-levator triamcinolone acetate injection
B1 Peri-levator and retrobulbar betamethasone injection
B2 Peri-levator and retrobulbar triamcinolone acetate injection
patients with isolated thyroid-related upper lid retraction who will be given the Peri-levator injection of betamethasone suspension
patients with isolated thyroid-related upper lid retraction who will be given Peri-levator injection of triamcinolone acetate
patients with thyroid-related upper lid retraction and proptosis who will be given Peri-levator and retrobulbar injection of betamethasone suspension
patients with thyroid-related upper lid retraction and proptosis who will be given Peri-levator and retrobulbar injection of triamcinolone acetate